Fernanda Ilary  Costa DUarte

Dr. Fernanda Ilary Costa DUarte


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SCSimone Braga Carneiro
Simone Braga Carneiro
FDFernanda Ilary Costa DUarte
Fernanda Ilary Costa DUarte
LHLuana Heimfath
Luana Heimfath
JQJullyana de Souza Siqueira Quintans
Jullyana de Souza Siqueira Quintans
LQLucindo Quintans-Junior
Lucindo Quintans-Junior
Ádley  LimaÁdley Lima
Ádley Lima
This review aims to provide a critical review of the biological performance of natural and synthetic substances complexed with cyclodextrins, highlighting: (i) inclusion complexes with cyclodextrins and their biological studies in vitro and in vivo; (ii) Evaluation and comparison of the bioactive efficacy of complexed and non-complexed substances; (iii) Chemical and biological performance tests of inclusion complexes, aimed at the development of new pharmaceutical products. Based on the evidence presented in the review, it is clear that cyclodextrins play a vital role in the development of inclusion complexes which promote improvements in the chemical and biological properties of the complexed active principles, as well as providing improved solubility and aqueous stability. Although the literature shows the importance of their ability to help produce innovative biotechnological substances, we still need more studies to develop and expand their therapeutic properties. It is, therefore, very important to gather together evidence of the effectiveness of inclusion complexes with cyclodextrins in order to facilitate a better understanding of research on this topic and encourage further studies.

30 September 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VOVeronica Oliveira
Veronica Oliveira
AAAmanda Silva de Almeida
Amanda Silva de Almeida
IAIngrid Albuquerque
Ingrid Albuquerque
FDFernanda Ilary Costa DUarte
Fernanda Ilary Costa DUarte
BQBÁRBARA QUEIROZ
BÁRBARA QUEIROZ
Ádley  LimaÁdley Lima
Ádley Lima
This review aims to provide an overview of studies that address the use, in therapeutic applications, of solid dispersions (SDs) with biological activities in vitro and/or in vivo mainly made up of polymeric matrices, as well as to evaluate the bioactive activity of their constituents. This bibliographic survey shows that the development of solid dispersions provides benefits in the physicochemical properties of bioactive compounds, which lead to an increase in their biological potential. However, despite the reports found on solid dispersions, there is still a need for biological assay-based studies, mainly in vivo, to assist in the investigation and to devise new applications. Therefore, studies based on such an approach are of great importance to enhance and extend the use of solid dispersions in the most diverse therapeutic applications.

17 July 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
JFJamile Vitória Alves Freire
Jamile Vitória Alves Freire
FDFernanda Ilary Costa DUarte
Fernanda Ilary Costa DUarte
LDLivia Maria da Costa Dantas
Livia Maria da Costa Dantas
JSJulia Santana
Julia Santana
PAPatrícia Prado Augusto
Patrícia Prado Augusto
EOElissa Arantes Ostrosky
Elissa Arantes Ostrosky
The topical application of ferulic acid (FA) is limited by its low solubility and high susceptibility to oxidation. To overcome these limitations, the multicomponent system Cicloferulic® (CF) was developed by mixing FA, hydroxypropyl β-cyclodextrin (HPβ-CD), and polyvinylpyrrolidone K30 (PVP K30), which demonstrated greater safety and antioxidant efficacy than FA alone. The physicochemical characterization of FA, CF, and their components showed greater thermal stability and reduced crystallinity of CF, indicating the formation of the system. In cytotoxicity assays on HaCaT cells, FA maintained cell viability only up to 500 µg/mL, while CF maintained viability even at 10.000 µg/mL, demonstrating 20 times greater safety than FA. In cellular antioxidant activity assays, FA and CF showed similar effects at low concentrations. In the 1,1-diphenyl-2-picrylhydrazyl (DPPH) method, CF and FA reduced more than 70% of DPPH; however, CF contains only 12% FA, indicating an eightfold greater efficiency than FA. Formulations containing FA and CF increased the Sun Protection Factor (SPF) in vitro, even with a 50% reduction in UV filters. However, they did not stabilize formulations with intrinsically photolabile UV filters. In release studies, FA exhibited rapid flow, while CF promoted a modified release profile. Thus, CF stands out as an innovative, multifunctional system that can improve the stability, safety, and efficacy of FA for topical applications.